Los Angeles Capital Management LLC Biomarin Pharmaceutical Inc Transaction History
Los Angeles Capital Management LLC
- $24.2 Billion
- Q4 2024
A detailed history of Los Angeles Capital Management LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 38,529 shares of BMRN stock, worth $2.66 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
38,529
Previous 10,098
281.55%
Holding current value
$2.66 Million
Previous $709,000
257.12%
% of portfolio
0.01%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding BMRN
# of Institutions
626Shares Held
183MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.57 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.34 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.26 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$1.02 Billion0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$898 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.8B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...